Last edition
News about "Hangzhou Sciwind Biosciences "
Sciwind Signs Global Licensing Deal with Verdiva for Metabolic Disease Portfolio
Sciwind has granted Verdiva the exclusive global rights to develop, manufacture and commercialize the partnered programs outside of greater China and South Korea.
Hangzhou Sciwind Biosciences | 13/01/2025 | By Aishwarya | 407
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members